Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a national provider of patient-centered, healthcare-at-home solutions, and this news page focuses on its latest corporate and financial developments. The company’s public announcements describe a business centered on home medical equipment, medical supplies, and related services, organized into four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home.
Visitors to this AdaptHealth news feed can review press releases on quarterly earnings, financial guidance, capital structure updates, and ratings actions. Recent communications have included results for the second and third quarters, commentary on net revenue, net income, cash flow from operations, and the use of non-GAAP metrics such as Adjusted EBITDA, free cash flow, and organic revenue, as described by the company.
The news flow also covers strategic and operational updates. AdaptHealth has announced a definitive agreement to serve as the exclusive provider of home medical equipment and supplies for a major national healthcare system under a capitated model, as well as additional capitated agreements with payors. The company has reported dispositions of certain assets in its Wellness at Home segment and highlighted digital patient engagement initiatives through its own tools.
In addition, this page aggregates AdaptHealth’s disclosures about participation in healthcare and finance conferences, earnings release dates, and investor conference calls. For investors and observers tracking AHCO, the news stream provides direct access to the company’s own descriptions of its performance, partnerships, and healthcare-at-home operations across sleep, respiratory, diabetes, and wellness product categories.
AdaptHealth Corp. will participate in the BofA Securities 2024 Health Care Conference, with key executives engaging in a fireside chat. The Company offers patient-centered healthcare-at-home solutions, catering to over 4.1 million patients annually in all 50 states. AdaptHealth provides a wide range of medical products and services, including sleep therapy equipment, diabetes treatment supplies, HME devices, oxygen therapy, and other related services.
AdaptHealth Corp. announced financial results for the first quarter ended March 31, 2024. Net revenue increased by 6.4% to $792.5 million. However, net loss was $2.1 million compared to net income of $15.7 million in the same period last year. Adjusted EBITDA increased by 18.3% to $158.5 million. Cash flow from operations decreased to $49.0 million, and Free Cash Flow decreased to $(38.9) million due to delayed payments from the Change Healthcare data breach.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.